ABC transporters involved in drug resistance in human parasites

Essays in Biochemistry

Volumn 50, Issue 1, 2011, Pages 121-144

  Leprohon, Philippe ^a,b   Légaré, Danielle ^a,b   Ouellette, Marc ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APICOMPLEXA; ARCHAEA; ARCHEZOA; EUKARYOTA; KINETOPLASTIDA; TRYPANOSOMATIDAE; VERMES;

ABC TRANSPORTER;

ANIMAL; DRUG RESISTANCE; HOST PARASITE INTERACTION; HUMAN; PARASITOLOGY; PHYSIOLOGY; PROTOZOAL INFECTION; REVIEW;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE; HOST-PARASITE INTERACTIONS; HUMANS; PROTOZOAN INFECTIONS;

EID: 84856275069     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSE0500121     Document Type: Article

References (122)

1. BIO Ventures for Global Health Primer (2007) BVGH Global Health Primer, BVGH, Washington, DC
2. World Health Organization (2008) World Malaria Report 2008, World Health Organization, Geneva
3. Fitch, C.D. (2004) Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci. 74, 1957-1972
4. Dondorp, A.M., Nosten, F., Yi, P., Das, D., Phyo, A.P., Tarning, J., Lwin, K.M., Ariey, F., Hanpithakpong, W., Lee, S.J. et al. (2009) Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455-467
5. Wongsrichanalai, C. and Meshnick, S.R. (2008) Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg. Infect. Dis. 14, 716-719
6. Gardner, M.J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R.W., Carlton, J.M., Pain, A., Nelson, K.E., Bowman, S. et al. (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498-511
7. Sauvage, V., Aubert, D., Escotte-Binet, S. and Villena, I. (2009) The role of ATP-binding cassette (ABC) proteins in protozoan parasites. Mol. Biochem. Parasitol. 167, 81-94
8. Foote, S.J., Thompson, J.K., Cowman, A.F. and Kemp, D.J. (1989) Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57, 921-930
9. Wilson, C.M., Serrano, A.E., Wasley, A., Bogenschutz, M.P., Shankar, A.H. and Wirth, D.F. (1989) Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244, 1184-1186
10. Martin, S.K., Oduola, A.M. and Milhous, W.K. (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235, 899-901
11. Krogstad, D.J., Gluzman, I.Y., Kyle, D.E., Oduola, A.M., Martin, S.K., Milhous, W.K. and Schlesinger, P.H. (1987) Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238, 1283-1285
12. Barnes, D.A., Foote, S.J., Galatis, D., Kemp, D.J. and Cowman, A.F. (1992) Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J. 11, 3067-3075
13. Wellems, T.E., Panton, L.J., Gluzman, I.Y., do Rosario, V.E., Gwadz, R.W., Walker-Jonah, A. and Krogstad, D.J. (1990) Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345, 253-255
14. Sanchez, C.P., Dave, A., Stein, W.D. and Lanzer, M. (2010) Transporters as mediators of drug resistance in Plasmodium falciparum. Int. J. Parasitol. 40, 1109-1118
15. Martin, R.E., Marchetti, R.V., Cowan, A.I., Howitt, S.M., Broer, S. and Kirk, K. (2009) Chloroquine transport via the malaria parasite's chloroquine resistance transporter. Science 325, 1680-1682
16. Woodrow, C.J. and Krishna, S. (2006) Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance. Cell. Mol. Life Sci. 63, 1586-1596
17. Alker, A.P., Lim, P., Sem, R., Shah, N.K., Yi, P., Bouth, D.M., Tsuyuoka, R., Maguire, J.D., Fandeur, T., Ariey, F. et al. (2007) Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am. J. Trop. Med. Hyg. 76, 641-647
18. Price, R.N., Uhlemann, A.C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N.J. et al. (2004) Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364, 438-447
19. Sidhu, A.B., Uhlemann, A.C., Valderramos, S.G., Valderramos, J.C., Krishna, S. and Fidock, D.A. (2006) Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194, 528-535
20. Denis, M.B., Tsuyuoka, R., Poravuth, Y., Narann, T.S., Seila, S., Lim, C., Incardona, S., Lim, P., Sem, R., Socheat, D. et al. (2006) Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop. Med. Int. Health 11, 1360-1366
21. Lim, P., Chim, P., Sem, R., Nemh, S., Poravuth, Y., Lim, C., Seila, S., Tsuyuoka, R., Denis, M.B., Socheat, D. et al. (2005) In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002. Acta Trop. 93, 31-40
22. Foote, S.J., Kyle, D.E., Martin, R.K., Oduola, A.M., Forsyth, K., Kemp, D.J. and Cowman, A.F. (1990) Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345, 255-258
23. Sidhu, A.B., Valderramos, S.G. and Fidock, D.A. (2005) pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 57, 913-926
24. Adagu, I.S. and Warhurst, D.C. (2001) Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria. Parasitology 123, 219-224
25. Babiker, H.A., Pringle, S.J., Abdel-Muhsin, A., Mackinnon, M., Hunt, P. and Walliker, D. (2001) High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J. Infect. Dis. 183, 1535-1538
26. Mita, T., Kaneko, A., Hombhanje, F., Hwaihwanje, I., Takahashi, N., Osawa, H., Tsukahara, T., Masta, A., Lum, J.K., Kobayakawa, T. et al. (2006) Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea. Acta Trop. 98, 137-144
27. Duraisingh, M.T., Roper, C., Walliker, D. and Warhurst, D.C. (2000) Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol. Microbiol. 36, 955-961
28. Duraisingh, M.T., Jones, P., Sambou, I., von Seidlein, L., Pinder, M. and Warhurst, D.C. (2000) The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol. Biochem. Parasitol. 108, 13-23
29. Pickard, A.L., Wongsrichanalai, C., Purfield, A., Kamwendo, D., Emery, K., Zalewski, C., Kawamoto, F., Miller, R.S. and Meshnick, S.R. (2003) Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 47, 2418-2423
30. Dokomajilar, C., Nsobya, S.L., Greenhouse, B., Rosenthal, P.J. and Dorsey, G. (2006) Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob. Agents Chemother. 50, 1893-1895
31. Happi, C.T., Gbotosho, G.O., Folarin, O.A., Sowunmi, A., Hudson, T., O'Neil, M., Milhous, W., Wirth, D.F. and Oduola, A.M. (2009) Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 53, 888-895
32. Humphreys, G.S., Merinopoulos, I., Ahmed, J., Whitty, C.J., Mutabingwa, T.K., Sutherland, C.J. and Hallett, R.L. (2007) Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob. Agents Chemother. 51, 991-997
33. Mwai, L., Kiara, S.M., Abdirahman, A., Pole, L., Rippert, A., Diriye, A., Bull, P., Marsh, K., Borrmann, S. and Nzila, A. (2009) In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob. Agents Chemother. 53, 5069-5073
34. Sisowath, C., Stromberg, J., Martensson, A., Msellem, M., Obondo, C., Bjorkman, A. and Gil, J.P. (2005) In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 191, 1014-1017
35. Price, R.N., Uhlemann, A.C., van Vugt, M., Brockman, A., Hutagalung, R., Nair, S., Nash, D., Singhasivanon, P., Anderson, T.J., Krishna, S. et al. (2006) Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 42, 1570-1577
36. Sanchez, C.P., Rotmann, A., Stein, W.D. and Lanzer, M. (2008) Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Mol. Microbiol. 70, 786-798
37. Mu, J., Ferdig, M.T., Feng, X., Joy, D.A., Duan, J., Furuya, T., Subramanian, G., Aravind, L., Cooper, R.A., Wootton, J.C. et al. (2003) Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 49, 977-989
38. Anderson, T.J., Nair, S., Qin, H., Singlam, S., Brockman, A., Paiphun, L. and Nosten, F. (2005) Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrob. Agents Chemother. 49, 2180-2188
39. Cojean, S., Noël, A., Garnier, D., Hubert, V., Le Bras, J. and Durand, R. (2006) Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa. Malar. J. 5, 24
40. Raj, D.K., Mu, J., Jiang, H., Kabat, J., Singh, S., Sullivan, M., Fay, M.P., McCutchan, T.F. and Su, X.Z. (2009) Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J. Biol. Chem. 284, 7687-7696
41. Kavishe, R.A., van den Heuvel, J.M., van de Vegte-Bolmer, M., Luty, A.J., Russel, F.G. and Koenderink, J.B. (2009) Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane. Malar. J. 8, 205
42. Dahlstrom, S., Veiga, M.I., Martensson, A., Bjorkman, A. and Gil, J.P. (2009) Polymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine- pyrimethamine treatment. Antimicrob. Agents Chemother. 53, 2553-2556
43. Nogueira, F., Diez, A., Radfar, A., Pérez-Benavente, S., Rosario, V.E., Puyet, A. and Bautista, J.M. (2010) Early transcriptional response to chloroquine of the Plasmodium falciparum antioxidant defence in sensitive and resistant clones. Acta Trop. 114, 109-115
44. Zalis, M.G., Wilson, C.M., Zhang, Y. and Wirth, D.F. (1993) Characterization of the pfmdr2 gene for Plasmodium falciparum. Mol. Biochem. Parasitol. 62, 83-92
45. Ekong, R.M., Robson, K.J., Baker, D.A. and Warhurst, D.C. (1993) Transcripts of the multidrug resistance genes in chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Parasitology 106, 107-115
46. Rubio, J.P. and Cowman, A.F. (1994) Plasmodium falciparum: the pfmdr2 protein is not overex-pressed in chloroquine-resistant isolates of the malaria parasite. Exp. Parasitol. 79, 137-147
47. Rosenberg, E., Litus, I., Schwarzfuchs, N., Sinay, R., Schlesinger, P., Golenser, J., Baumeister, S., Lingelbach, K. and Pollack, Y. (2006) pfmdr2 confers heavy metal resistance to Plasmodium falciparum. J. Biol. Chem. 281, 27039-27045
48. Mead, J.R. (2002) Cryptosporidiosis and the challenges of chemotherapy. Drug Resist. Updat. 5, 47-57
49. Bonafonte, M.T., Romagnoli, P.A., McNair, N., Shaw, A.P., Scanlon, M., Leitch, G.J. and Mead, J.R. (2004) Cryptosporidium parvum: effect of multi-drug reversing agents on the expression and function of ATP-binding cassette transporters. Exp. Parasitol. 106, 126-134
50. Zapata, F., Perkins, M.E., Riojas, Y.A., Wu, T.W. and Le Blancq, S.M. (2002) The Cryptosporidium parvum ABC protein family. Mol. Biochem. Parasitol. 120, 157-161
51. Perkins, M.E., Riojas, Y.A., Wu, T.W. and Le Blancq, S.M. (1999) CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages. Proc. Natl. Acad. Sci. U.S.A. 96, 5734-5739
52. Benitez, A.J., McNair, N. and Mead, J. (2007) Modulation of gene expression of three Cryptosporidium parvum ATP-binding cassette transporters in response to drug treatment. Parasitol. Res. 101, 1611-1616
53. Benitez, A.J., Arrowood, M.J. and Mead, J.R. (2009) Functional characterization of the nucleotide binding domain of the Cryptosporidium parvum CpABC4 transporter: an iron-sulfur cluster transporter homolog. Mol. Biochem. Parasitol. 165, 103-110
54. Lira, R., Sundar, S., Makharia, A., Kenney, R., Gam, A., Saraiva, E. and Sacks, D. (1999) Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J. Infect. Dis. 180, 564-567
55. Croft, S.L., Sundar, S. and Fairlamb, A.H. (2006) Drug resistance in leishmaniasis. Clin. Microbiol. Rev. 19, 111-126
56. Sundar, S., Jha, T.K., Thakur, C.P., Sinha, P.K. and Bhattacharya, S.K. (2007) Injectable paromomycin for visceral leishmaniasis in India. N. Engl. J. Med. 356, 2571-2581
57. Ivens, A.C., Peacock, C.S., Worthey, E.A., Murphy, L., Aggarwal, G., Berriman, M., Sisk, E., Rajandream, M.A., Adlem, E., Aert, R. et al. (2005) The genome of the kinetoplastid parasite, Leishmania major. Science 309, 436-442
58. Leprohon, P., Legare, D., Girard, I., Papadopoulou, B. and Ouellette, M. (2006) Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites. Eukaryotic Cell 5, 1713-1725
59. Araujo-Santos, J.M., Parodi-Talice, A., Castanys, S. and Gamarro, F. (2005) The overexpression of an intracellular ABCA-like transporter alters phospholipid trafficking in Leishmania. Biochem. Biophys. Res. Commun. 330, 349-355
60. Parodi-Talice, A., Araujo, J.M., Torres, C., Perez-Victoria, J.M., Gamarro, F. and Castanys, S. (2003) The overexpression of a new ABC transporter in Leishmania is related to phospholipid trafficking and reduced infectivity. Biochim. Biophys. Acta 1612, 195-207
61. Decuypere, S., Rijal, S., Yardley, V., De Doncker, S., Laurent, T., Khanal, B., Chappuis, F. and Dujardin, J.C. (2005) Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob. Agents Chemother. 49, 4616-4621
62. Singh, N. (2006) Drug resistance mechanisms in clinical isolates of Leishmania donovani. Indian J. Med. Res. 123, 411-422
63. Ouellette, M., Fase-Fowler, F. and Borst, P. (1990) The amplified H circle of methotrexate-resistant leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J. 9, 1027-1033
64. Deeley, R.G. and Cole, S.P. (2006) Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 580, 1103-1111
65. Fairlamb, A.H. and Cerami, A. (1992) Metabolism and functions of trypanothione in the Kinetoplastida. Annu. Rev. Microbiol. 46, 695-729
66. Ouellette, M., Drummelsmith, J. and Papadopoulou, B. (2004) Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist. Updat. 7, 257-266
67. Leprohon, P., Legare, D. and Ouellette, M. (2009) Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials. Antimicrob. Agents Chemother. 53, 2646-2649
68. V reducing activity correlates with antimony susceptibility in Leishmania donovani. J. Biol. Chem. 276, 3971-3976
69. Gourbal, B., Sonuc, N., Bhattacharjee, H., Legare, D., Sundar, S., Ouellette, M., Rosen, B.P. and Mukhopadhyay, R. (2004) Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J. Biol. Chem. 279, 31010-31017
70. Marquis, N., Gourbal, B., Rosen, B.P., Mukhopadhyay, R. and Ouellette, M. (2005) Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Mol. Microbiol. 57, 1690-1699
71. Legare, D., Richard, D., Mukhopadhyay, R., Stierhof, Y.D., Rosen, B.P., Haimeur, A., Papadopoulou, B. and Ouellette, M. (2001) The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J. Biol. Chem. 276, 26301-26307
72. Dey, S., Ouellette, M., Lightbody, J., Papadopoulou, B. and Rosen, B.P. (1996) An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae. Proc. Natl. Acad. Sci. U.S.A. 93, 2192-2197
73. Mukherjee, A., Padmanabhan, P.K., Singh, S., Roy, G., Girard, I., Chatterjee, M., Ouellette, M. and Madhubala, R. (2007) Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J. Antimicrob. Chemother. 59, 204-211
74. Singh, R., Kumar, D., Duncan, R.C., Nakhasi, H.L. and Salotra, P. (2010) Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites. Int. J. Antimicrob. Agents 36, 50-57
75. Jha, T.K. (1983) Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India. Trans. R. Soc. Trop. Med. Hyg. 77, 167-170
76. Basselin, M., Denise, H., Coombs, G.H. and Barrett, M.P. (2002) Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion. Antimicrob. Agents Chemother. 46, 3731-3738
77. Coelho, A.C., Beverley, S.M. and Cotrim, P.C. (2003) Functional genetic identifcation of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major. Mol. Biochem. Parasitol. 130, 83-90
78. Coelho, A.C., Messier, N., Ouellette, M. and Cotrim, P.C. (2007) Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes. Antimicrob. Agents Chemother. 51, 3030-3032
79. Coelho, A.C., Gentil, L.G., da Silveira, J.F. and Cotrim, P.C. (2008) Characterization of Leishmania (Leishmania) amazonensis promastigotes resistant to pentamidine. Exp. Parasitol. 120, 98-102
80. Dodge, M.A., Waller, R.F., Chow, L.M., Zaman, M.M., Cotton, L.M., McConville, M.J. and Wirth, D.F. (2004) Localization and activity of multidrug resistance protein 1 in the secretory pathway of Leishmania parasites. Mol. Microbiol. 51, 1563-1575
81. Wong, I.L., Chan, K.F., Burkett, B.A., Zhao, Y., Chai, Y., Sun, H., Chan, T.H. and Chow, L.M. (2007) Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in Leishmania. Antimicrob. Agents Chemother. 51, 930-940
82. Wong, I.L., Chan, K.F., Zhao, Y., Chan, T.H. and Chow, L.M. (2009) Quinacrine and a novel apigenin dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite Leishmania. J. Antimicrob. Chemother. 63, 1179-1190
83. Perez-Victoria, F.J., Sanchez-Canete, M.P., Seifert, K., Croft, S.L., Sundar, S., Castanys, S. and Gamarro, F. (2006) Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use. Drug Resist. Updat. 9, 26-39
84. Castanys-Munoz, E., Alder-Baerens, N., Pomorski, T., Gamarro, F. and Castanys, S. (2007) A novel ATP-binding cassette transporter from Leishmania is involved in transport of phosphatidylcholine analogues and resistance to alkyl-phospholipids. Mol. Microbiol. 64, 1141-1153
85. Castanys-Munoz, E., Perez-Victoria, J.M., Gamarro, F. and Castanys, S. (2008) Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement. Antimicrob. Agents Chemother. 52, 3573-3579
86. BoseDasgupta, S., Ganguly, A., Roy, A., Mukherjee, T. and Majumder, H.K. (2008) A novel ATP-binding cassette transporter, ABCG6 is involved in chemoresistance of Leishmania. Mol. Biochem. Parasitol. 158, 176-188
87. Katakura, K., Fujise, H., Takeda, K., Kaneko, O., Torii, M., Suzuki, M., Chang, K.P. and Hashiguchi, Y. (2004) Overexpression of LaMDR2, a novel multidrug resistance ATP-binding cassette transporter, causes 5-fluorouracil resistance in Leishmania amazonensis. FEBS Lett. 561, 207-212
88. Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D.C., Lennard, N.J., Caler, E., Hamlin, N.E., Haas, B. et al. (2005) The genome of the African trypanosome Trypanosoma brucei. Science 309, 416-422
89. El-Sayed, N.M., Myler, P.J., Bartholomeu, D.C., Nilsson, D., Aggarwal, G., Tran, A.N., Ghedin, E., Worthey, E.A., Delcher, A.L., Blandin, G. et al. (2005) The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309, 409-415
90. Brun, R., Schumacher, R., Schmid, C., Kunz, C. and Burri, C. (2001) The phenomenon of treatment failures in human African trypanosomiasis. Trop. Med. Int. Health 6, 906-914
91. Matovu, E., Stewart, M.L., Geiser, F., Brun, R., Maser, P., Wallace, L.J., Burchmore, R.J., Enyaru, J.C., Barrett, M.P., Kaminsky, R. et al. (2003) Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Eukaryotic Cell 2, 1003-1008
92. Shahi, S.K., Krauth-Siegel, R.L. and Clayton, C.E. (2002) Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei. Mol. Microbiol. 43, 1129-1138
93. Alibu, V.P., Richter, C., Voncken, F., Marti, G., Shahi, S., Renggli, C.K., Seebeck, T., Brun, R. and Clayton, C. (2006) The role of Trypanosoma brucei MRPA in melarsoprol susceptibility. Mol. Biochem. Parasitol. 146, 38-44
94. Robinson, S.C. and Mirchandani, G. (1965) Trichomonas vaginalis. V. Further observations on metronidazole (Flagyl) (including infant follow-up). Am. J. Obstet. Gynecol. 93, 502-505
95. Ayala, P., Samuelson, J., Wirth, D. and Orozco, E. (1990) Entamoeba histolytica: physiology of multidrug resistance. Exp. Parasitol. 71, 169-175
96. Samuelson, J.C., Burke, A. and Courval, J.M. (1992) Susceptibility of an emetine-resistant mutant of Entamoeba histolytica to multiple drugs and to channel blockers. Antimicrob. Agents Chemother. 36, 2392-2397
97. Descoteaux, S., Ayala, P., Samuelson, J. and Orozco, E. (1995) Increase in mRNA of multiple Eh pgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. Gene 164, 179-184
98. Lopez-Camarillo, C., Luna-Arias, J.P., Marchat, L.A. and Orozco, E. (2003) EhPgp5 mRNA stability is a regulatory event in the Entamoeba histolytica multidrug resistance phenotype. J. Biol. Chem. 278, 11273-11280
99. Ghosh, S.K., Lohia, A., Kumar, A. and Samuelson, J. (1996) Overexpression of P-glycoprotein gene 1 by transfected Entamoeba histolytica confers emetine-resistance. Mol. Biochem. Parasitol. 82, 257-260
100. Banuelos, C., Orozco, E., Gomez, C., Gonzalez, A., Medel, O., Mendoza, L. and Perez, D.G. (2002) Cellular location and function of the P-glycoproteins (EhPgps) in Entamoeba histolytica multidrug-resistant trophozoites. Microb. Drug Resist. 8, 291-300
101. Carlton, J.M., Hirt, R.P., Silva, J.C., Delcher, A.L., Schatz, M., Zhao, Q., Wortman, J.R., Bidwell, S.L., Alsmark, U.C., Besteiro, S. et al. (2007) Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 315, 207-212
102. Johnson, P.J., Schuck, B.L. and Delgadillo, M.G. (1994) Analysis of a single-domain P-glycoprotein-like gene in the early-diverging protist Trichomonas vaginalis. Mol. Biochem. Parasitol. 66, 127-137
103. Albonico, M., Bickle, Q., Ramsan, M., Montresor, A., Savioli, L. and Taylor, M. (2003) Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull. W.H.O. 81, 343-352
104. Sacko, M., De Clercq, D., Behnke, J.M., Gilbert, F.S., Dorny, P. and Vercruysse, J. (1999) Comparison of the efficacy of mebendazole, albendazole and pyrantel in treatment of human hookworm infections in the southern region of Mali, West Africa. Trans. R. Soc. Trop. Med. Hyg. 93, 195-203
105. Doenhoff, M.J., Cioli, D. and Utzinger, J. (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 21, 659-667
106. Hayeshi, R., Masimirembwa, C., Mukanganyama, S. and Ungell, A.L. (2006) The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Eur. J. Pharm. Sci. 29, 70-81
107. Berriman, M., Haas, B.J., LoVerde, P.T., Wilson, R.A., Dillon, G.P., Cerqueira, G.C., Mashiyama, S.T., Al-Lazikani, B., Andrade, L.F., Ashton, P.D. et al. (2009) The genome of the blood fluke Schistosoma mansoni. Nature 460, 352-358
108. Zhou, Y., Zheng, H., Chen, Y., Zhang, L., Wang, K., Guo, J., Huang, Z., Zhang, B., Huang, W., Jin, K. et al. (2009) The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 460, 345-351
109. Kasinathan, R.S., Goronga, T., Messerli, S.M., Webb, T.R. and Greenberg, R.M. (2010) Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel. FASEB J. 24, 128-135
110. Messerli, S.M., Kasinathan, R.S., Morgan, W., Spranger, S. and Greenberg, R.M. (2009) Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility. Mol. Biochem. Parasitol. 167, 54-59
111. Pica-Mattoccia, L., Doenhoff, M.J., Valle, C., Basso, A., Troiani, A.R., Liberti, P., Festucci, A., Guidi, A. and Cioli, D. (2009) Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni. Acta Trop. 111, 82-85
112. Bosch, I.B., Wang, Z.X., Tao, L.F. and Shoemaker, C.B. (1994) Two Schistosoma mansoni cDNAs encoding ATP-binding cassette (ABC) family proteins. Mol. Biochem. Parasitol. 65, 351-356
113. Prichard, R. (2001) Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends Parasitol. 17, 445-453
114. Osei-Atweneboana, M.Y., Eng, J.K., Boakye, D.A., Gyapong, J.O. and Prichard, R.K. (2007) Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369, 2021-2029
115. Bourguinat, C., Pion, S.D., Kamgno, J., Gardon, J., Duke, B.O., Boussinesq, M. and Prichard, R.K. (2007) Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl. Trop. Dis. 1, e72
116. Prichard, R.K. and Roulet, A. (2007) ABC transporters and β-tubulin in macrocyclic lactone resistance: prospects for marker development. Parasitology 134, 1123-1132
117. Ardelli, B.F., Guerriero, S.B. and Prichard, R.K. (2006) Characterization of a half-size ATP-binding cassette transporter gene which may be a useful marker for ivermectin selection in Onchocerca volvulus. Mol. Biochem. Parasitol. 145, 94-100
118. Bourguinat, C., Ardelli, B.F., Pion, S.D., Kamgno, J., Gardon, J., Duke, B.O., Boussinesq, M. and Prichard, R.K. (2008) P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol. Biochem. Parasitol. 158, 101-111
119. Ardelli, B.F., Guerriero, S.B. and Prichard, R.K. (2005) Genomic organization and effects of ivermectin selection on Onchocerca volvulus P-glycoprotein. Mol. Biochem. Parasitol. 143, 58-66
120. Ardelli, B.F. and Prichard, R.K. (2004) Identification of variant ABC-transporter genes among Onchocerca volvulus collected from ivermectin-treated and untreated patients in Ghana, West Africa. Ann. Trop. Med. Parasitol. 98, 371-384
121. Molento, M.B. and Prichard, R.K. (1999) Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus). Parasitol. Res. 85, 1007-1011
122. James, C.E. and Davey, M.W. (2009) Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans. Int. J. Parasitol. 39, 213-220